GlassScriptPhysician profile
Michael Allan Burnham
NPI 1538228580
$3,707.99
in general payments reported to CMS, 2019-2025
5 companies · $444 in 2025
The $444 reported for 2025 was more than what 76% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $1,785 · 2021: $307 · 2022: $361 · 2023: $403 · 2024: $155 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675 · Gift: $227 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.19 |
| Gift | $226.76 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $3,444.38 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $177.20 | 2019-2021 | |
| Zimvie INC. | $52.11 | 2022 | |
| Kls-Martin L.P. | $18.09 | 2021 | |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $16.21 | 2024 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Burnham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.